342 filings
Page 8 of 18
8-K
qzwdbxcyn0cv syes
20 May 10
Departure of Directors or Certain Officers
12:00am
8-K
w51q 03vcqfc7hh
10 May 10
ARIAD Reports First Quarter 2010 Financial Results and Development Progress
12:00am
8-K
xep c9byt5r
6 May 10
ARIAD Announces Restructuring of Its Ridaforolimus Collaboration with Merck
12:00am
8-K
a0yajcvc
3 May 10
Departure of Directors or Certain Officers
12:00am
8-K
otzl7dc3g0vvm9tml9
15 Apr 10
ARIAD Names Robert Whelan, Jr. to Board of Directors
12:00am
8-K
qp5c17wum8h2es
23 Mar 10
ARIAD Announces Court Ruling Regarding NF-κB Patent Lawsuit with Lilly
12:00am
8-K
zjcy9nvaejpiiqwwtn5
16 Mar 10
ARIAD Reports Development Progress and Fourth Quarter and Year-End 2009 Financial Results
12:00am
8-K
ahu1d3wv1h z27cbel0
1 Mar 10
ARIAD Receives Orphan Drug Designations for Its Investigational pan BCR-ABL Inhibitor, AP24534, in Chronic Myeloid Leukemia
12:00am
8-K
22evfd cpvx4f1al
22 Jan 10
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
5quddrzhcy46xhc
17 Dec 09
ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
12:00am
8-K
vv7deyrol46ca
15 Dec 09
Other Events
12:00am
8-K
okam 0khro
7 Dec 09
ARIAD Presents Positive Clinical Proof-of-Concept Data on AP24534 in Drug-Resistant Hematological Cancers at ASH Annual Meeting
12:00am
8-K
2nj5iqmy
5 Nov 09
ARIAD Reports Third Quarter 2009 Development Progress and Financial Results
12:00am
8-K
cgr1zcevcwam47f 05u0
23 Sep 09
ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab
12:00am
8-K
fkdoz01qrc9id5i3dxi
27 Aug 09
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
6v6839b
4 Aug 09
Ariad Prices Public Offering of Common Stock
12:00am
8-K
mbre83dndnwtr0h
3 Aug 09
Ariad Announces Proposed Public Offering of Common Stock
12:00am
8-K
lovgknvq xa3aw5
30 Jul 09
Ariad Reports Second Quarter 2009 Financial Results and Development Progress
12:00am
8-K
j7jqenqthhhhoq3w0xz7
28 Jul 09
Other Events
12:00am
8-K
m7xrfjld2xube90f5w
25 Jun 09
Departure of Directors or Certain Officers
12:00am